Dr. rer. nat. Petra Gross-Demel

Dr. rer. nat. Petra Gross-Demel is a scientist and clinical project manager at the Division of Infectious Diseases and Tropical Medicine of the LMU Munich. Petra is part of the development team managing phase II studies of the new investigational antibiotic BTZ-043 for tuberculosis.

Petra has been working for more than 20 years in clinical development at Sandoz/Novartis and in a CRO. As a globally acting Clinical Research Manager she managed phase I and III studies and developed global clinical program designs of superiority- pharmacokinetic-, bioequivalence-, non-inferiority, equivalence-studies including compilation or review of clinical and bioanalytical protocols, ICF, CRF, validation and bioanalytical reports under consideration of drug metabolism.